For: | Lee CZ, Lee HS, Huang GT, Yang PM, Sheu JC. Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment. World J Gastroenterol 2006; 12(33): 5301-5305 [PMID: 16981258 DOI: 10.3748/wjg.v12.i33.5301] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i33/5301.htm |
Number | Citing Articles |
1 |
Yu-Min Choi, So-Young Lee, Bum-Joon Kim. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World Journal of Gastroenterology 2018; 24(16): 1708-1724 doi: 10.3748/wjg.v24.i16.1708
|
2 |
Jinxin Zheng, Zheng Zeng, Duyi Zhang, Yanyan Yu, Fang Wang, Calvin Q. Pan. Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients. Liver International 2012; 32(10): 1535 doi: 10.1111/j.1478-3231.2012.02859.x
|
3 |
Bhupesh Singla, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. Journal of Medical Virology 2013; 85(7): 1155 doi: 10.1002/jmv.23608
|
4 |
Fatemeh Dolati, Emad Behboudi, Malihe Naderi, Iraj Shahramian, Abdolvahab Moradi. Evaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients. Iranian Journal of Medical Microbiology 2022; 16(1): 66 doi: 10.30699/ijmm.16.1.66
|
5 |
Philip Vutien, Huy N. Trinh, Ruel T. Garcia, Huy A. Nguyen, Brian S. Levitt, Khanh Nguyen, Eduardo da Silveira, Tami Daugherty, Aijaz Ahmed, Gabriel Garcia, Glen A. Lutchman, Mindie H. Nguyen. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Clinical Gastroenterology and Hepatology 2014; 12(8): 1363 doi: 10.1016/j.cgh.2013.11.036
|
6 |
Amitis Ramezani, Ali Akbar Velayati, Mohammad Reza Hasanjani Roshan, Latif Gachkar, Mohammad Banifazl, Hossein Keyvani, Arezoo Aghakhani. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. International Journal of Infectious Diseases 2008; 12(3): 252 doi: 10.1016/j.ijid.2007.08.003
|
7 |
Hakan Alagozlu, Ozturk Ozdemir, Binnur Koksal, Abdulkerim Yilmaz, Mahmut Coskun. Prevelance of Common YMDD Motif Mutations in Long Term Treated Chronic HBV Infections in a Turkish Population. Asian Pacific Journal of Cancer Prevention 2013; 14(9): 5489 doi: 10.7314/APJCP.2013.14.9.5489
|
8 |
M. H. NGUYEN, R. T. GARCIA, H. N. TRINH, H. A. NGUYEN, K. K. NGUYEN, L. H. NGUYEN, B. LEVITT. Prevalence of hepatitis B virus DNA polymerase mutations in treatment‐naïve patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2009; 30(11-12): 1150 doi: 10.1111/j.1365-2036.2009.04151.x
|
9 |
Masoumeh Rezanezhadi, Alireza Mohebbi, Fatemeh Sana Askari, Seyyede Delafruz Hosseini, Alijan Tabarraei. Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients. VirusDisease 2019; 30(2): 219 doi: 10.1007/s13337-018-00510-5
|
10 |
Perumal Vivekanandan, Om Vir Singh. Molecular methods in the diagnosis and management of chronic hepatitis B. Expert Review of Molecular Diagnostics 2010; 10(7): 921 doi: 10.1586/erm.10.75
|
11 |
Federico A. Di Lello, Ezequiel Ridruejo, Alfredo P. Martínez, Paula S. Pérez, Rodolfo H. Campos, Diego M. Flichman. Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure. Journal of Viral Hepatitis 2019; 26(5): 552 doi: 10.1111/jvh.13052
|